Can removing bladder tumors in one piece improve cancer outcomes?
NCT ID NCT07724886
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This trial tests whether a newer surgical method called en bloc resection, which removes bladder tumors in one piece, works better than the standard piecemeal approach for people with intermediate- or high-risk non-muscle-invasive bladder cancer. All participants also receive a year of intravesical BCG immunotherapy. The study aims to see which technique leads to fewer cancer recurrences.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- transurethral en bloc resection of bladder tumour plus intravesical bacillus Calmette-Guerin therapy
- What this could lead to
- If en bloc resection proves superior, it could become the new standard surgical approach for intermediate- and high-risk non-muscle-invasive bladder cancer, potentially reducing recurrence rates.
- What could go wrong
- This is a large but early-stage comparison; the new technique may not improve outcomes over the standard approach and could carry different surgical risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
North District Hospital
Sheung Shui, Hong Kong
Contact Email: •••••@•••••
-
Prince of Wales Hospital
Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an AI agent match expert urologists? a major test begins
- Can a hybrid surgical technique better remove large bladder tumors?
- Can an AI camera on a catheter spot bladder cancer better than standard scopes?
- Bladder cancer breakthrough? new combo aims to save the bladder
- Targeted Antibody-Drug combo aims to tackle High-Risk bladder cancer
- New combination aims to save bladders in Muscle-Invasive cancer